Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Net Income towards Common Stockholders of $75.43 million for Q2 2026, up 89.6% from $39.78 million a year earlier and up 132.2% from the prior quarter.
Harmony Biosciences Holdings (HRMY) Net Income towards Common Stockholders (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Harmony Biosciences Holdings was $181.27 million, up 0.2% year-over-year; for FY2025, it came in at $158.69 million, up 9.1% from FY2024.
- In prior years, Harmony Biosciences Holdings' Net Income towards Common Stockholders was $145.49 million in FY2024 (+12.9%), $128.85 million in FY2023 (-29.0%), $181.47 million in FY2022 (+424.5%) and $34.6 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Net Income towards Common Stockholders since Q3 2022.
- On a year-over-year basis, Net Income towards Common Stockholders increased in six of the last eight quarters, with growth averaging 48.1%.
- The strongest year-over-year quarter for Net Income towards Common Stockholders in the past five years was Q2 2025, with growth of 243.2%; the weakest was Q2 2024, with a decline of 66.2%.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was $32.49 million (Q1 2026), $22.49 million (Q4 2025) and $50.87 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Harmony Biosciences Holdings | 2.30 Bn | -452.73 Mn | 198.08 Mn | 75.43 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.43 Mn |
| Mar 31, 2026 | 32.49 Mn |
| Dec 31, 2025 | 22.49 Mn |
| Sep 30, 2025 | 50.87 Mn |
| Jun 30, 2025 | 39.78 Mn |
| Mar 31, 2025 | 45.56 Mn |
| Dec 31, 2024 | 49.48 Mn |
| Sep 30, 2024 | 46.09 Mn |
| Jun 30, 2024 | 11.59 Mn |
| Mar 31, 2024 | 38.33 Mn |
| Dec 31, 2023 | 26.61 Mn |
| Sep 30, 2023 | 38.46 Mn |
| Jun 30, 2023 | 34.30 Mn |
| Mar 31, 2023 | 29.49 Mn |
| Dec 31, 2022 | 48.51 Mn |
| Sep 30, 2022 | 87.94 Mn |
| Jun 30, 2022 | 23.53 Mn |
| Mar 31, 2022 | 21.49 Mn |
| Dec 31, 2021 | 22.71 Mn |
| Sep 30, 2021 | -9.62 Mn |
Harmony Biosciences Holdings Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();